Synchromed Corp.
Country not established
- Devices
- 1
What Synchromed Corp. makes
Synchromed Corp. manufactures the TRANS-PACE 100, a neurostimulation device designed for spinal cord stimulation therapy to manage chronic pain.
The device is classified as Class II under FDA regulations and is authorised via the 510(k) pathway. The company is based in the United States.
Catalogue
Trans-Pace 100 Ref K900220
510(k) 510(k)
Frequently asked questions
How many devices does Synchromed Corp. have in the registry?
The registry currently lists 1 device for Synchromed Corp.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Synchromed Corp.'s devices?
Among its 1 most recently registered device, Synchromed Corp. has devices listed in FDA 510(k) (1 device).
What risk classes do Synchromed Corp.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Synchromed Corp.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Synchromed Corp. in the registry?
The most recently registered devices listed for Synchromed Corp. include TRANS-PACE 100.